10-Q Filing

BIO-PATH HOLDINGS, INC. CIK: 1133818 Q1 2015

Filing Information

Form Type	10-Q
Accession Number	`0001144204-15-029223`
Period End Date	20150331
Filing Date	20150511
Fiscal Year	2015
Fiscal Period	Q1
XBRL Instance	bpth-20150331.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 68 Income Statement 22 Cash Flow Statement 30

Balance Sheet 68 line items

Line Item	Tag	Value	Unit	Period
Preferred Stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred Stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred Stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred Stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred Stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash	`Cash`	$12.45M	USD	Point-in-time
Cash	`Cash`	$16.82M	USD	Point-in-time
Cash	`Cash`	$3.55M	USD	Point-in-time
Cash	`Cash`	$13.86M	USD	Point-in-time
Preferred Stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred Stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Prepaid drug product for testing	`OtherInventory`	$358.90K	USD	Point-in-time
Prepaid drug product for testing	`OtherInventory`	$154.67K	USD	Point-in-time
Preferred Stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$122.64K	USD	Point-in-time
Common Stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$100.49K	USD	Point-in-time
Common Stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total current assets	`AssetsCurrent`	$12.94M	USD	Point-in-time
Common Stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Common Stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$14.11M	USD	Point-in-time
Common Stock, shares issued	`CommonStockSharesIssued`	89.76M	shares	Point-in-time
Common Stock, shares issued	`CommonStockSharesIssued`	89.76M	shares	Point-in-time
Furniture, fixtures & equipment	`PropertyPlantAndEquipmentGross`	$123.41K	USD	Point-in-time
Common Stock, shares outstanding	`CommonStockSharesOutstanding`	89.76M	shares	Point-in-time
Furniture, fixtures & equipment	`PropertyPlantAndEquipmentGross`	$123.41K	USD	Point-in-time
Common Stock, shares outstanding	`CommonStockSharesOutstanding`	89.76M	shares	Point-in-time
Less Accumulated Depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$20.57K	USD	Point-in-time
Less Accumulated Depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$10.28K	USD	Point-in-time
Property, Plant and Equipment, Net	`PropertyPlantAndEquipmentNet`	$113.13K	USD	Point-in-time
Property, Plant and Equipment, Net	`PropertyPlantAndEquipmentNet`	$102.84K	USD	Point-in-time
Technology licenses	`FiniteLivedLicenseAgreementsGross`	$2.50M	USD	Point-in-time
Technology licenses	`FiniteLivedLicenseAgreementsGross`	$2.50M	USD	Point-in-time
Less Accumulated Amortization	`FiniteLivedIntangibleAssetsAccumulatedAmortization`	$1.25M	USD	Point-in-time
Less Accumulated Amortization	`FiniteLivedIntangibleAssetsAccumulatedAmortization`	$1.29M	USD	Point-in-time
Intangible Assets, Net (Excluding Goodwill), Total	`IntangibleAssetsNetExcludingGoodwill`	$1.21M	USD	Point-in-time
Intangible Assets, Net (Excluding Goodwill), Total	`IntangibleAssetsNetExcludingGoodwill`	$1.25M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$15.48M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$14.25M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$76.56K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$41.03K	USD	Point-in-time
Accounts payable - related party	`AccountsPayableRelatedPartiesCurrentAndNoncurrent`	$100.45K	USD	Point-in-time
Accounts payable - related party	`AccountsPayableRelatedPartiesCurrentAndNoncurrent`	-	USD	Point-in-time
Accrued expense	`AccruedLiabilitiesCurrent`	$253.44K	USD	Point-in-time
Accrued expense	`AccruedLiabilitiesCurrent`	$539.67K	USD	Point-in-time
Accrued expense - related party	`AccruedLiabilitiesRelatedPartiesCurrent`	-	USD	Point-in-time
Accrued expense - related party	`AccruedLiabilitiesRelatedPartiesCurrent`	$67.05K	USD	Point-in-time
Accrued license payments - related party	`DueToRelatedPartiesCurrent`	$100.00K	USD	Point-in-time
Accrued license payments - related party	`DueToRelatedPartiesCurrent`	-	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$561.97K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$616.22K	USD	Point-in-time
Long term debt	`LongTermDebtNoncurrent`	-	USD	Point-in-time
Long term debt	`LongTermDebtNoncurrent`	-	USD	Point-in-time
TOTAL LIABILITIES	`Liabilities`	$616.22K	USD	Point-in-time
TOTAL LIABILITIES	`Liabilities`	$561.97K	USD	Point-in-time
Preferred Stock, $.001 par value 10,000,000 shares authorized, no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred Stock, $.001 par value 10,000,000 shares authorized, no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common Stock, $.001 par value, 200,000,000 shares authorized 89,762,872 and 89,762,872 shares issued and outstanding as of 3/31/15 and 12/31/14, respectively	`CommonStockValue`	$89.76K	USD	Point-in-time
Common Stock, $.001 par value, 200,000,000 shares authorized 89,762,872 and 89,762,872 shares issued and outstanding as of 3/31/15 and 12/31/14, respectively	`CommonStockValue`	$89.76K	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$34.83M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$34.74M	USD	Point-in-time
Accumulated deficit	`DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage`	$21.29M	USD	Point-in-time
Accumulated deficit	`DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage`	$19.92M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$14.92M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$13.63M	USD	Point-in-time
TOTAL LIABILITIES & SHAREHOLDERS' EQUITY	`LiabilitiesAndStockholdersEquity`	$14.25M	USD	Point-in-time
TOTAL LIABILITIES & SHAREHOLDERS' EQUITY	`LiabilitiesAndStockholdersEquity`	$15.48M	USD	Point-in-time

Income Statement 22 line items

Line Item	Tag	Value	Unit	Period
Revenue	`Revenues`	-	USD	1 Quarter
Revenue	`Revenues`	-	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$592.48K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$107.64K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$380.85K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$786.41K	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$510.21K	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$1.38M	USD	1 Quarter
Net operating loss	`OperatingIncomeLoss`	$-1.38M	USD	1 Quarter
Net operating loss	`OperatingIncomeLoss`	$-510.21K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$5.57K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$4.25K	USD	1 Quarter
Other expense	`OtherNonoperatingExpense`	-	USD	1 Quarter
Other expense	`OtherNonoperatingExpense`	$239.00	USD	1 Quarter
Total Other Income (Expense)	`NonoperatingIncomeExpense`	$5.33K	USD	1 Quarter
Total Other Income (Expense)	`NonoperatingIncomeExpense`	$4.25K	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-1.37M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-504.88K	USD	1 Quarter
Net loss per share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.01	USD	1 Quarter
Net loss per share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.02	USD	1 Quarter
Basic and diluted weighted average number of common shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	89.24M	shares	1 Quarter
Basic and diluted weighted average number of common shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	89.76M	shares	1 Quarter

Cash Flow Statement 30 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-1.37M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-504.88K	USD	1 Quarter
Amortization	`AdjustmentForAmortization`	$40.16K	USD	1 Quarter
Amortization	`AdjustmentForAmortization`	$40.16K	USD	1 Quarter
Depreciation	`Depreciation`	-	USD	1 Quarter
Depreciation	`Depreciation`	$10.28K	USD	1 Quarter
Stock-based compensation and warrants	`ShareBasedCompensation`	$86.28K	USD	1 Quarter
Stock-based compensation and warrants	`ShareBasedCompensation`	$91.29K	USD	1 Quarter
Prepaid drug product for testing	`IncreaseDecreaseInInventories`	$197.69K	USD	1 Quarter
Prepaid drug product for testing	`IncreaseDecreaseInInventories`	$204.23K	USD	1 Quarter
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$93.35K	USD	1 Quarter
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$22.14K	USD	1 Quarter
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$54.25K	USD	1 Quarter
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$125.06K	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-544.42K	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-1.41M	USD	1 Quarter
Net proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	-	USD	1 Quarter
Net proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$13.81M	USD	1 Quarter
Net cash from financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$13.81M	USD	1 Quarter
Net cash from financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	-	USD	1 Quarter
NET INCREASE (DECREASE) IN CASH	`CashPeriodIncreaseDecrease`	$13.27M	USD	1 Quarter
NET INCREASE (DECREASE) IN CASH	`CashPeriodIncreaseDecrease`	$-1.41M	USD	1 Quarter
Cash, beginning of period	`Cash`	$12.45M	USD	Point-in-time
Cash, beginning of period	`Cash`	$16.82M	USD	Point-in-time
Cash, beginning of period	`Cash`	$3.55M	USD	Point-in-time
Cash, beginning of period	`Cash`	$13.86M	USD	Point-in-time
Cash, end of period	`Cash`	$12.45M	USD	Point-in-time
Cash, end of period	`Cash`	$16.82M	USD	Point-in-time
Cash, end of period	`Cash`	$3.55M	USD	Point-in-time
Cash, end of period	`Cash`	$13.86M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.